Regeneca recalls all lots of single capsule packet RegenErect
Regeneca has issued a voluntary recall of all lots of single capsule packet RegenErect, labeled as a dietary supplement.
RegenErect is a blue capsule sold individually in foil packets with a UPC code of 816860010055.
The company has confirmed the presence of Tadalafil, an FDA-approved drug used as treatment for male erectile dysfunction, making these products unapproved new drugs.
The active drug ingredient is not listed on the label for these products, the company said.
The products may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels.
Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs
This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250